WASHINGTON – House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 ( 5133) today to prohibit pharmaceutical companies from engaging in anticompetitive “product hopping.” The bill is scheduled to be marked up in the Judiciary Committee on Wednesday. “Big pharmaceutical companies have done everything they can to increase their profits regardless of who it affects. Their CEOs make millions in bonuses ever year while hardworking folks are forced to ration their medicine just so they can put food on the table for their…
Read More »